Daniel D. Burgess - Jul 28, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role: Director
Signature: /s/ Robert Crotty, by power of attorney
Stock symbol: NBRV
Transactions as of: Jul 28, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/30/2021, 08:23 PM
Previous filing: Jun 24, 2021
Next filing: Aug 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBRV	Ordinary Shares	Award	$0	+17.5K	+327.1%	$0.00	22.9K	Jul 28, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBRV	Share Options	Award	$0	+35K		$0.00	35K	Jul 28, 2021	Ordinary Shares	35K	$1.08	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
F2	The number of ordinary shares reported on this Form 4 reflects a 1-for-10 reverse stock split effected on December 3, 2020.
F3	The option was granted on July 28, 2021.
F4	One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.